| 产品编号 | D50402 |
| 英文名称 | EX-527 |
| 中文名称 | |
| 别 名 | EX 527 (Selisistat); 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide; EX527 cpd; Selisistat; SEN0014196; SIRT1 Inhibitor III; HY-15452; Selisistat (EX 527); SIRT1 Inhibitor; SIRT1抑制剂 |
 |
Specific References (1) | D50402 has been referenced in 1 publications.
[IF=3.329] Su, Pei-Pei. et al. Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy. MILITARY MED RES. 2022 Dec;9(1):1-13 Mouse.
|
| 克 隆 号 | |
| CAS | 49843-98-3 |
| 理论分子量 | kDa |
| 检测分子量 | |
| 保存条件 | Store at -20℃ stable for at least 12 months. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 产品介绍 |
CAS：49843-98-3 分子式：C13H13ClN2O 分子量：248.71 MDL：MFCD03009471 纯度：≥98% 熔点：178℃ 沸点：531.72℃/760mmHg 溶解性：Soluble in DMSO (10 mg/ml), ethanol (5 mg/ml), DMF (~20 mg/ml), and DMSO:PBS (1:1 pH 7.2) (~0.5 mg/ml). 溶解性：Water <1mg/ml; DMSO 50mg/ml; Ethanol 18mg/ml 作用靶点：Sirtuin; 作用通路：Cell Cycle/DNA Damage; Epigenetics; 用途及描述：Selisistat (EX-527) 是一种有效，选择性的 SIRT1 抑制剂，IC50 为 98 nM。对SIRT2和SIRT3极弱的抑制作用。 |
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
